Initial Statement of Beneficial Ownership (Form 3)

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Schultes Birgit C 2. Date of Event Requiring Statement (Month/Day/Year) 01/13/2025 3. Issuer Name and Ticker or Trading Symbol Intellia Therapeutics, Inc. [NTLA] (Last) (First) (Middle) C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET, SUITE 130 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Chief Scientific Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) CAMBRIDGE, MA 02139 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 67,615(1) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)	3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(2)	10/01/2027	Common Stock	40,000	$27.33	D
Stock Option (right to buy)	(3)	12/11/2027	Common Stock	20,000	$18.3	D
Stock Option (right to buy)	(4)	12/17/2028	Common Stock	10,625	$14.58	D
Stock Option (right to buy)	(5)	03/01/2030	Common Stock	30,000	$13.4	D
Stock Option (right to buy)	(6)	03/02/2031	Common Stock	20,600	$57.71	D
Stock Option (right to buy)	(7)	09/30/2031	Common Stock	3,500	$134.06	D
Stock Option (right to buy)	(8)	02/28/2033	Common Stock	24,965	$40.75	D
Stock Option (right to buy)	(9)	02/28/2034	Common Stock	31,816	$32.66	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Director	10% Owner	Officer	Other
Schultes Birgit C C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE, MA 02139			EVP, Chief Scientific Officer

Signatures

James Basta, attorney-in-fact	01/23/2025
**Signature of Reporting Person	Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes (i) a grant of 16,080 restricted stock units, (ii) a grant of 7,500 restricted stock units, (iii) a grant of 3,440 restricted stock units, (iiii) a grant of 400 restricted stock units, (v) a grant of 20,839 restricted stock units, (vi) a grant of 17,668 restricted stock units, and (vii) a grant of 22,045 restricted stock units, each representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
(2)	This option was granted on October 2, 2017 with respect to 40,000 shares of Common Stock, with 25% vesting on September 18, 2018 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(3)	This option was granted on December 12, 2017 with respect to 20,000 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(4)	This option was granted on December 18, 2018 with respect to 30,000 shares of Common Stock, with 25% vesting on December 18, 2019 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(5)	This option was granted on March 2, 2020 with respect to 30,000 shares of Common Stock, with 25% vesting on January 1, 2021 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(6)	This option was granted on March 3, 2021 with respect to 20,600 shares of Common Stock, with 25% vesting on January 1, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(7)	This option was granted on October 1, 2021 with respect to 3,500 shares of Common Stock, with 25% vesting on October 1, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter.
(8)	This option was granted on March 1, 2023 with respect to 24,965 shares of Common Stock, with 33% vesting on January 1, 2024 and the remaining 67% vesting in twenty-four (24) substantially equal monthly installments thereafter.
(9)	This option was granted on March 1, 2024 with respect to 31,816 shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in twenty-four (24) substantially equal monthly installments thereafter.
Remarks: Exhibit 24.1 - Power of Attorney.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Public link

Please use the above public link if you want to share this noodl on another website.